Guardian Pharmacy Services (NYSE:GRDN) Insider Sells $19,928,101.76 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) insider Fred Burke sold 671,432 shares of Guardian Pharmacy Services stock in a transaction on Friday, March 20th. The shares were sold at an average price of $29.68, for a total value of $19,928,101.76. Following the completion of the sale, the insider directly owned 840,413 shares of the company’s stock, valued at $24,943,457.84. This trade represents a 44.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Guardian Pharmacy Services Stock Up 0.9%

Shares of GRDN opened at $37.58 on Wednesday. Guardian Pharmacy Services, Inc. has a 12-month low of $19.17 and a 12-month high of $38.12. The firm has a market capitalization of $2.38 billion, a PE ratio of 48.81 and a beta of 0.86. The stock’s fifty day simple moving average is $32.49 and its 200-day simple moving average is $29.83.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Wednesday, March 11th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.27 by $0.10. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 31.64%. The company had revenue of $397.62 million during the quarter, compared to analysts’ expectations of $390.04 million. The company’s quarterly revenue was up 17.4% on a year-over-year basis. Analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several large investors have recently modified their holdings of GRDN. Ameritas Investment Partners Inc. raised its position in shares of Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after acquiring an additional 345 shares during the last quarter. California State Teachers Retirement System boosted its position in shares of Guardian Pharmacy Services by 3.4% during the 4th quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock valued at $541,000 after purchasing an additional 593 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in Guardian Pharmacy Services by 7.1% in the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock worth $258,000 after purchasing an additional 805 shares during the period. Police & Firemen s Retirement System of New Jersey grew its stake in shares of Guardian Pharmacy Services by 20.4% in the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock valued at $183,000 after buying an additional 1,028 shares during the period. Finally, State of Alaska Department of Revenue bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $30,000.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on GRDN shares. Raymond James Financial restated an “outperform” rating and set a $40.00 target price on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. UBS Group reaffirmed a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th. Truist Financial upped their target price on Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Finally, Oppenheimer increased their target price on Guardian Pharmacy Services from $35.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, March 12th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Guardian Pharmacy Services currently has a consensus rating of “Buy” and an average target price of $38.00.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.